• Home
  • Medical Devices
Full-length Transcriptome Sequencing - Global and China Top Players Market Share and Ranking 2023

Full-length Transcriptome Sequencing - Global and China Top Players Market Share and Ranking 2023

Report Code: KNJ1587608 | No. of Pages: 133 | Category: Medical Devices
Publisher: YH Research | Date of Publish: Mar-2023 
According to YH Research, the global market for Full-length Transcriptome Sequencing should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China Full-length Transcriptome Sequencing market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029. The United States Full-length Transcriptome Sequencing market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By segment, Biomedical Field grew percent to account for percent of the total market sales, and Non-medical Field grew percent.
This report studies and analyses global Full-length Transcriptome Sequencing status and future trends, to help determine the Full-length Transcriptome Sequencing market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Full-length Transcriptome Sequencing, and provides market size (US$ million) and Year-over-Year growth, considering 2022 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global Full-length Transcriptome Sequencing market size, history data 2018-2023, and forecast data 2024-2029, (US$ million)
(2) Global Full-length Transcriptome Sequencing by company, revenue, market share and industry ranking 2018-2023, (US$ million)
(3) China Full-length Transcriptome Sequencing by company, revenue, market share and industry ranking 2018-2023, (US$ million)
(4) Global Full-length Transcriptome Sequencing key consuming regions, consumption value and demand structure
(5) Full-length Transcriptome Sequencing industry chains, upstream, midstream and downstream
Market segment by players, this report covers
    Illumina
    Thermo Fisher Scientific
    Bio-Rad
    Agilent Technologies
    QIAGEN
    Eurofins Scientific
    Azenta
    LabCorp
    BGI Genomics
Market segment by Type, covers
    Total RNA
    Noncoding RNA
Market segment by Application, can be divided into
    Biomedical Field
    Non-medical Field
Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa
Report Includes:
Chapter 1: to describe Full-length Transcriptome Sequencing product scope, global consumption value, China consumption value, development opportunities, challenges, trends, and policies.
Chapter 2: Global Full-length Transcriptome Sequencing market share and ranking of major manufacturers, revenue, 2018-2023
Chapter 3: China Full-length Transcriptome Sequencing market share and ranking of major manufacturers, revenue, 2018-2023
Chapter 4: Full-length Transcriptome Sequencing industry chain, upstream, medium-stream, and downstream.
Chapter 5: Segment by Type, consumption value, percent & CAGR, 2018-2029
Chapter 6: Segment by Application, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment in regional level, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in country level, consumption value, percent & CAGR, 2018-2029
Chapter 9: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, revenue, gross margin.
Chapter 10: Conclusions
1 Market Overview
    1.1 Full-length Transcriptome Sequencing Definition
    1.2 Global Full-length Transcriptome Sequencing Market Size and Forecast
    1.3 China Full-length Transcriptome Sequencing Market Size and Forecast
    1.4 China Percentage in Global Market
    1.5 Full-length Transcriptome Sequencing Market Size: China VS Global Growth Rate, 2018-2029
    1.6 Full-length Transcriptome Sequencing Market Dynamics
        1.6.1 Full-length Transcriptome Sequencing Market Drivers
        1.6.2 Full-length Transcriptome Sequencing Market Restraints
        1.6.3 Full-length Transcriptome Sequencing Industry Trends
        1.6.4 Full-length Transcriptome Sequencing Industry Policy
2 Global Leading Players and Market Share
    2.1 By Revenue of Full-length Transcriptome Sequencing, Global Market Share by Company, 2018-2023
    2.2 Global Full-length Transcriptome Sequencing Participants, Market Position (Tier 1, Tier 2, and Tier 3)
    2.3 Global Full-length Transcriptome Sequencing Concentration Ratio
    2.4 Global Full-length Transcriptome Sequencing Mergers & Acquisitions, Expansion Plans
    2.5 Global Full-length Transcriptome Sequencing Major Companies Product Type
    2.6 Head Office and Full-length Transcriptome Sequencing Production Site of Key Manufacturer
3 China Leading Players, Market Share and Ranking
    3.1 By Revenue of Full-length Transcriptome Sequencing, China Market Share by Company, 2018-2023
    3.2 China Full-length Transcriptome Sequencing Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Industry Chain Analysis
    4.1 Full-length Transcriptome Sequencing Industry Chain
    4.2 Full-length Transcriptome Sequencing Upstream Analysis
        4.2.1 Full-length Transcriptome Sequencing Core Raw Materials
        4.2.2 Main Manufacturers of Full-length Transcriptome Sequencing Core Raw Materials
    4.3 Midstream Analysis
    4.4 Downstream Analysis
    4.5 Full-length Transcriptome Sequencing Production Mode
    4.6 Full-length Transcriptome Sequencing Procurement Model
    4.7 Full-length Transcriptome Sequencing Industry Sales Model and Sales Channels
        4.7.1 Full-length Transcriptome Sequencing Sales Model
        4.7.2 Full-length Transcriptome Sequencing Typical Distributors
5 Sights by Type
    5.1 Full-length Transcriptome Sequencing Classification
        5.1.1 Total RNA
        5.1.2 Noncoding RNA
    5.2 By Type, Global Full-length Transcriptome Sequencing Consumption Value & CAGR, 2018 VS 2022 VS 2029
    5.3 By Type, Global Full-length Transcriptome Sequencing Consumption Value, 2018-2029
6 Sights by Application
    6.1 Full-length Transcriptome Sequencing Segment by Application
        6.1.1 Biomedical Field
        6.1.2 Non-medical Field
    6.2 By Application, Global Full-length Transcriptome Sequencing Consumption Value & CAGR, 2018 VS 2022 VS 2029
    6.3 By Application, Global Full-length Transcriptome Sequencing Consumption Value, 2018-2029
7 Sales Sights by Region
    7.1 By Region, Global Full-length Transcriptome Sequencing Consumption Value, 2018 VS 2022 VS 2029
    7.2 By Region, Global Full-length Transcriptome Sequencing Consumption Value, 2018-2029
    7.3 North America
        7.3.1 North America Full-length Transcriptome Sequencing & Forecasts, 2018-2029
        7.3.2 By Country, North America Full-length Transcriptome Sequencing Market Size Market Share
    7.4 Europe
        7.4.1 Europe Full-length Transcriptome Sequencing Market Size & Forecasts, 2018-2029
        7.4.2 By Country, Europe Full-length Transcriptome Sequencing Market Size Market Share
    7.5 Asia Pacific
        7.5.1 Asia Pacific Full-length Transcriptome Sequencing Market Size & Forecasts, 2018-2029
        7.5.2 By Country/Region, Asia Pacific Full-length Transcriptome Sequencing Market Size Market Share
    7.6 South America
        7.6.1 South America Full-length Transcriptome Sequencing Market Size & Forecasts, 2018-2029
        7.6.2 By Country, South America Full-length Transcriptome Sequencing Market Size Market Share
    7.7 Middle East & Africa
8 Sales Sights by Country Level
    8.1 By Country, Global Full-length Transcriptome Sequencing Market Size & CAGR, 2018 VS 2022 VS 2029
    8.2 By Country, Global Full-length Transcriptome Sequencing Consumption Value, 2018-2029
    8.3 U.S.
        8.3.1 U.S. Full-length Transcriptome Sequencing Market Size, 2018-2029
        8.3.2 By Type, U.S. Full-length Transcriptome Sequencing Consumption Value Market Share, 2022 VS 2029
        8.3.3 By Application, U.S. Full-length Transcriptome Sequencing Consumption Value Market Share, 2022 VS 2029
    8.4 Europe
        8.4.1 Europe Full-length Transcriptome Sequencing Market Size, 2018-2029
        8.4.2 By Type, Europe Full-length Transcriptome Sequencing Consumption Value Market Share, 2022 VS 2029
        8.4.3 By Application, Europe Full-length Transcriptome Sequencing Consumption Value Market Share, 2022 VS 2029
    8.5 China
        8.5.1 China Full-length Transcriptome Sequencing Market Size, 2018-2029
        8.5.2 By Type, China Full-length Transcriptome Sequencing Consumption Value Market Share, 2022 VS 2029
        8.5.3 By Application, China Full-length Transcriptome Sequencing Consumption Value Market Share, 2022 VS 2029
    8.6 Japan
        8.6.1 Japan Full-length Transcriptome Sequencing Market Size, 2018-2029
        8.6.2 By Type, Japan Full-length Transcriptome Sequencing Consumption Value Market Share, 2022 VS 2029
        8.6.3 By Application, Japan Full-length Transcriptome Sequencing Consumption Value Market Share, 2022 VS 2029
    8.7 South Korea
        8.7.1 South Korea Full-length Transcriptome Sequencing Market Size, 2018-2029
        8.7.2 By Type, South Korea Full-length Transcriptome Sequencing Consumption Value Market Share, 2022 VS 2029
        8.7.3 By Application, South Korea Full-length Transcriptome Sequencing Consumption Value Market Share, 2022 VS 2029
    8.8 Southeast Asia
        8.8.1 Southeast Asia Full-length Transcriptome Sequencing Market Size, 2018-2029
        8.8.2 By Type, Southeast Asia Full-length Transcriptome Sequencing Consumption Value Market Share, 2022 VS 2029
        8.8.3 By Application, Southeast Asia Full-length Transcriptome Sequencing Consumption Value Market Share, 2022 VS 2029
    8.9 India
        8.9.1 India Full-length Transcriptome Sequencing Market Size, 2018-2029
        8.9.2 By Type, India Full-length Transcriptome Sequencing Consumption Value Market Share, 2022 VS 2029
        8.9.3 By Application, India Full-length Transcriptome Sequencing Consumption Value Market Share, 2022 VS 2029
    8.10 Middle East & Africa
        8.10.1 Middle East & Africa Full-length Transcriptome Sequencing Market Size, 2018-2029
        8.10.2 By Type, Middle East & Africa Full-length Transcriptome Sequencing Consumption Value Market Share, 2022 VS 2029
        8.10.3 By Application, Middle East & Africa Full-length Transcriptome Sequencing Consumption Value Market Share, 2022 VS 2029
9 Company Profile
    9.1 Illumina
        9.1.1 Illumina Company Information, Head Office, Market Area and Industry Position
        9.1.2 Illumina Company Profile and Main Business
        9.1.3 Illumina Full-length Transcriptome Sequencing Models, Specifications and Application
        9.1.4 Illumina Full-length Transcriptome Sequencing Revenue and Gross Margin, 2018-2023
        9.1.5 Illumina Recent Developments
    9.2 Thermo Fisher Scientific
        9.2.1 Thermo Fisher Scientific Company Information, Head Office, Market Area and Industry Position
        9.2.2 Thermo Fisher Scientific Company Profile and Main Business
        9.2.3 Thermo Fisher Scientific Full-length Transcriptome Sequencing Models, Specifications and Application
        9.2.4 Thermo Fisher Scientific Full-length Transcriptome Sequencing Revenue and Gross Margin, 2018-2023
        9.2.5 Thermo Fisher Scientific Recent Developments
    9.3 Bio-Rad
        9.3.1 Bio-Rad Company Information, Head Office, Market Area and Industry Position
        9.3.2 Bio-Rad Company Profile and Main Business
        9.3.3 Bio-Rad Full-length Transcriptome Sequencing Models, Specifications and Application
        9.3.4 Bio-Rad Full-length Transcriptome Sequencing Revenue and Gross Margin, 2018-2023
        9.3.5 Bio-Rad Recent Developments
    9.4 Agilent Technologies
        9.4.1 Agilent Technologies Company Information, Head Office, Market Area and Industry Position
        9.4.2 Agilent Technologies Company Profile and Main Business
        9.4.3 Agilent Technologies Full-length Transcriptome Sequencing Models, Specifications and Application
        9.4.4 Agilent Technologies Full-length Transcriptome Sequencing Revenue and Gross Margin, 2018-2023
        9.4.5 Agilent Technologies Recent Developments
    9.5 QIAGEN
        9.5.1 QIAGEN Company Information, Head Office, Market Area and Industry Position
        9.5.2 QIAGEN Company Profile and Main Business
        9.5.3 QIAGEN Full-length Transcriptome Sequencing Models, Specifications and Application
        9.5.4 QIAGEN Full-length Transcriptome Sequencing Revenue and Gross Margin, 2018-2023
        9.5.5 QIAGEN Recent Developments
    9.6 Eurofins Scientific
        9.6.1 Eurofins Scientific Company Information, Head Office, Market Area and Industry Position
        9.6.2 Eurofins Scientific Company Profile and Main Business
        9.6.3 Eurofins Scientific Full-length Transcriptome Sequencing Models, Specifications and Application
        9.6.4 Eurofins Scientific Full-length Transcriptome Sequencing Revenue and Gross Margin, 2018-2023
        9.6.5 Eurofins Scientific Recent Developments
    9.7 Azenta
        9.7.1 Azenta Company Information, Head Office, Market Area and Industry Position
        9.7.2 Azenta Company Profile and Main Business
        9.7.3 Azenta Full-length Transcriptome Sequencing Models, Specifications and Application
        9.7.4 Azenta Full-length Transcriptome Sequencing Revenue and Gross Margin, 2018-2023
        9.7.5 Azenta Recent Developments
    9.8 LabCorp
        9.8.1 LabCorp Company Information, Head Office, Market Area and Industry Position
        9.8.2 LabCorp Company Profile and Main Business
        9.8.3 LabCorp Full-length Transcriptome Sequencing Models, Specifications and Application
        9.8.4 LabCorp Full-length Transcriptome Sequencing Revenue and Gross Margin, 2018-2023
        9.8.5 LabCorp Recent Developments
    9.9 BGI Genomics
        9.9.1 BGI Genomics Company Information, Head Office, Market Area and Industry Position
        9.9.2 BGI Genomics Company Profile and Main Business
        9.9.3 BGI Genomics Full-length Transcriptome Sequencing Models, Specifications and Application
        9.9.4 BGI Genomics Full-length Transcriptome Sequencing Revenue and Gross Margin, 2018-2023
        9.9.5 BGI Genomics Recent Developments
10 Conclusion
11 Appendix
    11.1 Research Methodology
    11.2 Data Source
        11.2.1 Secondary Sources
        11.2.2 Primary Sources
    11.3 Market Estimation Model
    11.4 Disclaimer

NEED Help?

If you need any help or guidance, please feel free to call us.

USA : +1 (661) 636 6162

INDIA : +91 9325802062

or

Write us on : sales@kandjmarketresearch.com